MG
IDXX icon

Michael Gelband’s Idexx Laboratories IDXX Stock Holding History

Michael Gelband’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.83M Buy
+12,971
New +$7.28M 0.04% 398
2026
Q1 		– Sell
-22,386
Closed -$15.1M – 1803
2025
Q4 		$15.1M Buy
+22,386
New +$15.2M 0.12% 152
2025
Q1 		– Sell
-55,793
Closed -$23.1M – 1714
2024
Q4 		$23.1M Buy
+55,793
New +$24.5M 0.16% 107
2024
Q1 		– Sell
-5,497
Closed -$3.05M – 1699
2023
Q4 		$3.05M Buy
5,497
+2,885
+110% +$1.35M 0.02% 457
2023
Q3 		$1.14M Buy
+2,612
New +$1.3M 0.01% 913
2023
Q2 		– Sell
-11,286
Closed -$5.64M – 2035
2023
Q1 		$5.64M Sell
11,286
-5,122
-31% -$2.45M 0.05% 473
2022
Q4 		$6.69M Buy
16,408
+6,842
+72% +$2.66M 0.1% 273
2022
Q3 		$3.12M Buy
+9,566
New +$3.51M 0.04% 577
2022
Q2 		– Sell
-11,485
Closed -$6.28M – 2152
2022
Q1 		$6.28M Buy
+11,485
New +$6.04M 0.08% 319
2021
Q4 		– Sell
-25,650
Closed -$16M – 2365
2021
Q3 		$16M Buy
25,650
+23,929
+1,390% +$16.1M 0.22% 100
2021
Q2 		$1.09M Sell
1,721
-8,839
-84% -$4.88M 0.01% 967
2021
Q1 		$5.17M Buy
10,560
+8,556
+427% +$4.29M 0.08% 256
2020
Q4 		$1M Buy
+2,004
New +$897K 0.01% 858
2020
Q1 		– Sell
-3,627
Closed -$947K – 1337
2019
Q4 		$947K Buy
+3,627
New +$956K 0.02% 574
2019
Q3 		– Sell
-2,312
Closed -$637K – 1472
2019
Q2 		$637K Buy
+2,312
New +$570K 0.03% 380
2019
Q1 		– Sell
-1,893
Closed -$352K – 711
2018
Q4 		$352K Buy
+1,893
New +$388K 0.02% 179

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Michael Gelband's IDXX Position: Q2 2026 in Review

Michael Gelband opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 12,971 shares worth $6.83M. The stake represents 0.04% of the portfolio and ranks #398 among its holdings. This is a return to the name: Michael Gelband previously reported a position in IDXX as recently as Q4 2025.

Michael Gelband first reported a position in IDXX in Q4 2018 and has held it in 16 quarters since. The position peaked at $23.1M in Q4 2024. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Michael Gelband held 12,971 shares of Idexx Laboratories worth $6.83M as of Q2 2026.
  • Idexx Laboratories was a new Michael Gelband position in Q2 2026.
  • Idexx Laboratories made up 0.04% of Michael Gelband's portfolio in Q2 2026, its #398 holding.
  • Michael Gelband first reported a position in Idexx Laboratories in Q4 2018 and has held it in 16 quarters since.
  • Michael Gelband's Idexx Laboratories position peaked at $23.1M in Q4 2024.
  • 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.